SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-027431
Filing Date
2018-11-06
Accepted
2018-11-06 16:17:30
Documents
54
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q acad-10q_20180930.htm 10-Q 1540248
2 EX-10.1 acad-ex101_302.htm EX-10.1 32284
3 EX-31.1 acad-ex311_6.htm EX-31.1 9510
4 EX-32.1 acad-ex321_10.htm EX-32.1 6383
  Complete submission text file 0001564590-18-027431.txt   5216226

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT acad-20180930.xml EX-101.INS 1128046
6 XBRL TAXONOMY EXTENSION SCHEMA acad-20180930.xsd EX-101.SCH 35803
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE acad-20180930_cal.xml EX-101.CAL 50583
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE acad-20180930_def.xml EX-101.DEF 91469
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE acad-20180930_lab.xml EX-101.LAB 269425
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acad-20180930_pre.xml EX-101.PRE 201269
Mailing Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130 858-558-2871
ACADIA PHARMACEUTICALS INC (Filer) CIK: 0001070494 (see all company filings)

IRS No.: 061376651 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50768 | Film No.: 181163213
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1